Ronald P DeMatteo Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

1/2015	Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes.
8/2011	Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ronald P DeMatteo Research Topics

Disease

113	Neoplasms (Cancer) 11/2023 - 01/2002
44	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2003
40	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2023 - 11/2002
18	Colorectal Neoplasms (Colorectal Cancer) 03/2023 - 02/2007
11	Sarcoma (Soft Tissue Sarcoma) 10/2023 - 11/2012
9	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 11/2002
7	Adenocarcinoma 12/2020 - 03/2006
6	Cholangiocarcinoma 01/2020 - 08/2014
5	Carcinoma (Carcinomatosis) 01/2018 - 03/2002
5	Pancreatic Neoplasms (Pancreatic Cancer) 11/2017 - 01/2012
5	Liver Failure 10/2017 - 10/2014
5	Margins of Excision 01/2017 - 02/2008
4	Inflammation (Inflammations) 01/2020 - 02/2010
4	Infections 12/2014 - 04/2007
3	Pancreatic Cyst 01/2018 - 01/2011
3	Jaundice (Icterus) 09/2017 - 03/2004
3	Fibrosis (Cirrhosis) 05/2017 - 03/2006
3	Neoplasms, Cystic, Mucinous, and Serous 12/2015 - 10/2012
3	Reperfusion Injury 10/2012 - 02/2010
3	Ischemia 10/2012 - 02/2010
3	Gallbladder Neoplasms (Gallbladder Cancer) 08/2011 - 03/2002
3	Peritonitis 05/2011 - 06/2008
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2016
2	COVID-19 01/2021 - 01/2021
2	Hyperbilirubinemia 05/2020 - 02/2014
2	Rectal Neoplasms (Rectal Cancer) 10/2019 - 06/2015
2	Hypophosphatemia 02/2019 - 10/2017
2	Lymphatic Metastasis 09/2018 - 01/2012
2	Cholangitis 09/2018 - 09/2017
2	Autoimmune Pancreatitis 01/2018 - 11/2011
2	Pancreatic Intraductal Neoplasms 01/2018 - 01/2011
2	Hepatitis 12/2017 - 03/2006
2	Pancreatic Fistula (Pancreatic Fistulas) 01/2017 - 05/2014
2	Klatskin Tumor 12/2015 - 03/2002
2	Carcinogenesis 12/2015 - 09/2012
2	Diabetes Mellitus 11/2015 - 01/2013
2	Liver Diseases (Liver Disease) 11/2015 - 11/2002
2	Hypoxia (Hypoxemia) 01/2015 - 08/2011
2	Abscess 05/2014 - 11/2007
2	Fatty Liver 01/2013 - 12/2003
2	Necrosis 09/2012 - 10/2008

Drug/Important Bio-Agent (IBA)

27	Imatinib Mesylate (Gleevec)FDA Link 11/2023 - 11/2002
7	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2013
7	Tyrosine Kinase InhibitorsIBA 10/2022 - 03/2007
7	Biomarkers (Surrogate Marker)IBA 06/2019 - 01/2012
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2006
6	AntigensIBA 04/2018 - 06/2003
5	Carcinoembryonic AntigenIBA 01/2018 - 02/2009
5	CytokinesIBA 10/2012 - 11/2006
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2023 - 01/2018
4	Phosphotransferases (Kinase)IBA 01/2019 - 08/2007
4	BilirubinIBA 09/2017 - 08/2009
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 12/2013
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 12/2011
3	Floxuridine (FUdR)FDA LinkGeneric 01/2020 - 08/2011
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019 - 11/2012
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019 - 10/2012
3	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2016
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2017 - 03/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 05/2009
3	Bevacizumab (Avastin)FDA Link 02/2015 - 08/2011
3	Hemoglobins (Hemoglobin)IBA 12/2013 - 12/2009
3	MucinsIBA 10/2012 - 01/2011
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 08/2023 - 09/2012
2	ChemokinesIBA 10/2022 - 07/2012
2	Interleukin-15 (Interleukin 15)IBA 10/2022 - 10/2007
2	Gemcitabine FDA Link 01/2020 - 07/2014
2	Phosphates (Orthophosphate)IBA 02/2019 - 10/2017
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2017
2	Indicators and Reagents (Reagents)IBA 01/2018 - 03/2004
2	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 01/2017
2	Immunoglobulin G (IgG)IBA 01/2018 - 11/2011
2	CateninsIBA 12/2017 - 01/2017
2	Fetal Proteins (Fetoprotein)IBA 12/2017 - 05/2017
2	LigandsIBA 01/2017 - 07/2012
2	pasireotideIBA 01/2017 - 05/2014
2	Messenger RNA (mRNA)IBA 01/2017 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 08/2011
2	Oncogene Proteins (Oncogene Protein)IBA 12/2013 - 08/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2013 - 12/2011
2	Interleukin-10 (Interleukin 10)IBA 03/2011 - 02/2010

Therapy/Procedure

42	Therapeutics 03/2023 - 11/2002
31	Hepatectomy 01/2024 - 01/2002
28	Drug Therapy (Chemotherapy) 01/2021 - 11/2003
10	Length of Stay 01/2024 - 03/2002
9	Immunotherapy 11/2023 - 09/2002
7	Neoadjuvant Therapy 10/2023 - 08/2013
7	Pancreatectomy 12/2020 - 04/2004
6	Transplantation 01/2018 - 11/2002
5	Pancreaticoduodenectomy 01/2022 - 08/2013
5	Laparotomy 09/2018 - 03/2002
4	Cholecystectomy 03/2015 - 03/2002
3	Operative Surgical Procedures 01/2021 - 09/2003
3	Radiotherapy 10/2019 - 10/2003
3	Liver Transplantation 01/2018 - 10/2011
3	Salvage Therapy 08/2015 - 08/2007
2	Ligation 01/2018 - 06/2008
2	Operative Time 01/2016 - 01/2013
2	Radiofrequency Ablation 12/2014 - 11/2007
2	Stents 02/2014 - 01/2014